Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanoma

Heather M. Gibson(Wayne State University)
Journal for ImmunoTherapy of Cancer
March 1, 2026
Cited by 0


Related Papers